Use of HER2-targeting antibody-drug conjugate in treatment of HER2-low expressing breast cancer

The disclosure provides uses of a HER2-targeting antibody-drug conjugate in the preparation of a medicine for treating patients with HER2-low expressing breast cancer.

Saved in:
Bibliographic Details
Main Authors FANG, JIAN-MIN, SU, XIAO-HONG
Format Patent
LanguageChinese
English
Published 01.04.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The disclosure provides uses of a HER2-targeting antibody-drug conjugate in the preparation of a medicine for treating patients with HER2-low expressing breast cancer.
Bibliography:Application Number: TW202211118596